Detection of malignant tumors: water-suppressed proton nuclear magnetic resonance spectroscopy of plasma
- PMID: 3683172
- DOI: 10.1002/mrm.1910050414
Detection of malignant tumors: water-suppressed proton nuclear magnetic resonance spectroscopy of plasma
Abstract
Average linewidths of methyl and methylene proton resonances of plasma lipoproteins from healthy controls and untreated cancer patients were measured in water-suppressed proton spectra obtained at 400 MHz. In contrast to a previous report (E. T. Fossel, J. M. Carr, and J. McDonagh, N. Engl. J. Med. 315, 1369 (1986] no statistically significant difference (P greater than 0.5) was found between the average linewidths in plasma samples from 20 normal controls (36.0 +/- 6.4 Hz) and 17 untreated cancer patients (34.6 +/- 6.3 Hz). When the effect of lactate was removed by graphical extrapolation, a small but marginally significant (P = 0.08) difference was observed between the average linewidths of the normal controls (35.1 +/- 5.8 Hz) and untreated cancer patients (31.8 +/- 5.2 Hz). However, there was still a large overlap between the two groups. In addition, substantial day to day variations in the linewidths of samples from the same individuals were observed. We conclude that these measurements cannot be used to detect cancer.
Similar articles
-
Assessment of proton nuclear magnetic resonance spectroscopy for detection of malignancy.Clin Chem. 1988 Mar;34(3):505-11. Clin Chem. 1988. PMID: 3349601
-
Detection of tumours with nuclear magnetic resonance spectroscopy of plasma.Eur J Cancer Clin Oncol. 1989 Mar;25(3):535-43. doi: 10.1016/0277-5379(89)90267-8. Eur J Cancer Clin Oncol. 1989. PMID: 2703007
-
[H-NMR spectroscopy of plasma cannot be used for cancer screening].Bull Cancer. 1988;75(8):795-800. Bull Cancer. 1988. PMID: 3179513 French.
-
The NMR blood test for cancer: current status.Cancer Cells. 1991 May;3(5):173-82. Cancer Cells. 1991. PMID: 1654067 Review.
-
Proton NMR spectroscopy of plasma lipoproteins: a marker of the immune function in cancer disease?Anticancer Res. 1994 Sep-Oct;14(5A):1839-51. Anticancer Res. 1994. PMID: 7847817 Review.
Cited by
-
Some factors that influence the plasma lipoprotein 1H NMR spectra of normal and cancer patients: an oncolipid test?Yale J Biol Med. 1991 Jan-Feb;64(1):63-77. Yale J Biol Med. 1991. PMID: 1897263 Free PMC article.
-
Nuclear magnetic resonance spectroscopy of plasma to distinguish between malignant and benign diseases causing jaundice and cholestasis.J Cancer Res Clin Oncol. 1993;119(10):622-6. doi: 10.1007/BF01372726. J Cancer Res Clin Oncol. 1993. PMID: 8335681 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources